New regulations from the Indian government

BNet is reporting that the Indian government may soon impose new regulations on clinical research outsourcing to its country, as well as create a Central Drug Authority to monitor clinical trials that are outsourced by North American and European Countries. It would look to protect patients in CROs in regions such as India, China and Africa. For more, read the article here.